Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis
JACC: Cardiovascular Interventions · 2024-11 · 17 (21) · 2472-2485
DOI: 10.1016/j.jcin.2024.09.003 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2024-11. Verfasst von Ignacio J Amat-Santos und 26 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital Clínico Universitario, Valladolid, Spain; Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares, Ins…. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Coronary Artery Disease, Severity of Illness Index, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Severe aortic stenosis (AS) coexists with coronary artery disease (CAD) in approximately 50% of patients. The preferred treatment is combined surgical aortic valve replacement (SAVR) and coronary artery bypass grafting (CABG). However, transcatheter aortic valve replacement (TAVR) along with percutaneous coronary intervention (PCI) has emerged as a viable alternative. OBJECTIVES: This study sought to compare the outcomes of PCI + TAVR vs CABG + SAVR. METHODS: This national multicenter retrospective study in Spain involved patients with severe AS and CAD treated between 2018 and 2021. Patients underwent either PCI + TAVR or CABG + SAVR and were compared. The primary endpoint was all-cause mortality and stroke at 1 year. Propensity score analysis was performed to mitigate baseline differences. RESULTS: Of the 1,342 included patients, 625 (46.6%) underwent PCI + TAVR, and 713 (53.1%) underwent CABG + SAVR. Patients in the percutaneous arm were older (age 81.6 ± 5.8 years vs 72.1 ± 7 years; P < 0.001), had a higher prevalence of chronic kidney disease (40.6% vs 14.9%; P < 0.001), and had higher Society of Thoracic Surgeons risk scores (4.3% [interquartile range (Q1-Q3): 2.8-6.4] vs 2.2% [Q1-Q3: 1.4-3.3]; P < 0.001). Technical success rates were 96% for PCI + TAVR and 98.4% for CABG + SAVR (P = 0.008), with similar periprocedural mortality (0.8% vs 0.7%; P = 0.999). However, the mortality + stroke rate at 30 days was higher in the CABG + SAVR group compared with PCI + TAVR, both in the unmatched (12.2% vs 4.7%; P = 0.005) and matched cohorts (8.8% vs 4.5%; P = 0.002), persisting at the 1-year follow-up. CONCLUSIONS: Despite a lower baseline risk, CABG + SAVR in patients with severe AS and CAD was associated with a higher rate of death and stroke compared with PCI + TAVR, highlighting the necessity for a large, randomized analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Hospital Clínico Universitario, Valladolid, Spain; Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: ijamat@…
- Cardiology Department, Hospital Clínico Universitario, Valladolid, Spain.
- Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain; Área Del Corazón, Hospital Universitario Central Asturias, Oviedo, Spain; Instituto de Investigación…
- Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain; Cardiology Department, Hospital Álvaro Cunqueiro, Vigo, Spain.
- Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain; Cardiology Department, Hospital Virgen de la Victoria, Málaga, Spain.
- Cardiology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
Zitieren
APA
Amat-Santos, I. J., García-Gómez, M., Avanzas, P., Jiménez-Diaz, V., Alonso-Briales, J. H., de la Torre Hernández, J. M., Sanz-Sánchez, J., Diarte-de Miguel, J. A., Sánchez-Recalde, Á., Nombela-Franco, L., Jiménez-Mazuecos, J., Serra, V., Nogales-Asensio, J. M., García-Blas, S., Gómez-Menchero, A., Del Valle, R., Mayor Déniz, C., Al Houssaini, W., Veiga-Fernández, G., …, & San Román, J. A. (2024). Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis. JACC: Cardiovascular Interventions, 17(21), 2472-2485. https://doi.org/10.1016/j.jcin.2024.09.003
Vancouver
Amat-Santos IJ, García-Gómez M, Avanzas P, Jiménez-Diaz V, Alonso-Briales JH, de la Torre Hernández JM, et al. Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis. JACC: Cardiovascular Interventions. 2024;17(21):2472-2485. doi:10.1016/j.jcin.2024.09.003
BibTeX
@article{AmatSantos2024,
author = {Amat-Santos, Ignacio J and García-Gómez, Mario and Avanzas, Pablo and Jiménez-Diaz, Víctor and Alonso-Briales, Juan H and de la Torre Hernández, José M and Sanz-Sánchez, Jorge and Diarte-de Miguel, José Antonio and Sánchez-Recalde, Ángel and Nombela-Franco, Luis and Jiménez-Mazuecos, Jesús and Serra, Vicenç and Nogales-Asensio, Juan Manuel and García-Blas, Sergio and Gómez-Menchero, Antonio and Del Valle, Raquel and Mayor Déniz, Carolina and Al Houssaini, Walid and Veiga-Fernández, Gabriela and Diez-Gil, José Luis and Jimeno Sánchez, Javier and López Menéndez, José and Fernández-Cordón, Clara and Gómez-Salvador, Itziar and Bustamante-Munguira, Juan and Kedhi, Elvin and San Román, J Alberto},
title = {Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {21},
pages = {2472--2485},
doi = {10.1016/j.jcin.2024.09.003}
}
EUVIMED